A new study by Professor Li Taisheng’s team at the Department of Infectious Diseases, PUMCH has shown that (5R)-5-hydroxytriptolide, the national Class I new drug developed by modifying the traditional Chinese medicine Tripterygium wilfordii Hook F (TwHF), is ...